Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02356549 · ClinicalTrials.gov registry record · NA
African American Cancer Clinical Trial Decisions: Testing Tailored Messages
A NA study of Lymphoma and Leukemia, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT02356549 is a NA study of Lymphoma and Leukemia that has completed, run by Virginia Commonwealth University. The registered enrollment target is 90 participants, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02356549, a NA study of Lymphoma and Leukemia, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if the use of tailored health messages and/or involving physicians are effective in increasing African American (AA) patient activation in a clinical trial consultation. The proposal will use a composite score for patient activation derived from the Street Patient Activation Coding system. This will help to determine the effectiveness of our intervention on patient activation and patient centered clinical trial decision.
Interventions
- BEHAVIORAL EMR Tailoring
- BEHAVIORAL Survey Tailoring
- BEHAVIORAL Physician Involvement
Study Locations (1)
Virginia
- Virginia Commonwealth University/Massey Cancer Center - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2015-05-01 |
| Est. Completion | 2020-03-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02356549
The ClinicalTrials.gov registry entry for NCT02356549 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (81% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Lymphoma appearing as the primary indexed condition, and to 3 interventions - of which EMR Tailoring is the first listed.
NCT02356549 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT02356549 about?
NCT02356549 is a clinical study titled "African American Cancer Clinical Trial Decisions: Testing Tailored Messages". The purpose of this study is to determine if the use of tailored health messages and/or involving physicians are effective in increasing African American (AA) patient activation in a clinical trial consultation. The proposal will use a composite score for patient activation derived from the Street P...
What is the current status of trial NCT02356549?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2015-05-01. Estimated completion is 2020-03-06.
What conditions does trial NCT02356549 study?
This clinical trial studies the following conditions: Lymphoma, Leukemia, Myeloma.
What interventions are being tested in trial NCT02356549?
The interventions under investigation include: EMR Tailoring (BEHAVIORAL), Survey Tailoring (BEHAVIORAL), Physician Involvement (BEHAVIORAL).
Who is sponsoring clinical trial NCT02356549?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02356549 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
-
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
RECRUITING · NA
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
RECRUITING · NA
-
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
RECRUITING · NA
-
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.